Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Piperazine derivatives as FASN inhibitors

Piperazine derivatives as FASN inhibitors

US Patent 9809552 · Granted Nov 7, 2017

Estimated economic value: $37,151,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

5-morpholin-4-yl-pyrazolo[4,3-b]pyridine derivatives2025
Quinolin-2-one derivatives2024
Quinolin-2-one derivatives2021
Quinolin-2-one derivatives2021
Quinolin-2-one derivatives2020
Tricyclic heterocylic derivatives2020
Combination of a 6-oxo-1,6-dihydro-pyridazine derivative having anti-cancer acti2020
Combination of a 6-oxo-1,6-dihydro-pyridazine derivative having anti-cancer acti2019
3-substituted cyclopentylamine derivatives2018
3-substituted cyclopentylamine derivatives2018
3-substituted cyclopentylamine derivatives2018
Cyclic amides as MetAP-2 inhibitors2018